6 Results for "

Activin receptor-like kinase-2

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "Activin receptor-like kinase-2" in MCE Product Catalog:

Cat. No.: HY-117887
CAS No.: 2141955-96-4
Synonyms: BLU-782; IPN-60130; ALK2-IN-1
Target:  

TGF-β Receptor

Research Areas:  

Cancer

Fidrisertib (BLU-782) is the orally active inhibitor for activin receptor-like kinase 2 (ALK2) that inhibits ALK2 R206H, ALK2, ALK1, ALK6, ALK3, ALK4, TGFβR2 and ALK5 with IC50s of 0.2, 0.6, 3, 24, 45, 65, 67 and 155 nM, respectively .
loading...
    loading...
Cat. No.: HY-136773
CAS No.: 2248154-85-8
Purity:  99.35%
Synonyms: ALK2-IN-4
Target:  

TGF-β Receptor

Research Areas:  

Metabolic Disease

KER047 (ALK2-IN-4) is a potent activin receptor-like kinase-2 (ALK2) inhibitor. KER047 can be used for the research of metabolic disease, such as fibrodysplasia ossificans progressiva (FOP).
loading...
    loading...
Cat. No.: HY-155939
CAS No.: 2863635-04-3
Purity:  98.30%
Target:  

TGF-β Receptor

Research Areas:  

Cancer

M4K2163 dihydrochloride is a potent, selective, blood-brain barrier (BBB) permeable activin receptor-like kinase-2 (ALK2) inhibitor, with an IC50 of 19 nM. M4K2163 dihydrochloride can be used in the research of diffuse intrinsic pontine glioma (DIPG) .
loading...
    loading...
Cat. No.: HY-161377
CAS No.: 3034840-25-7
Target:  

TGF-β Receptor

Research Areas:  

Cancer

M4K2306 is a selective inhibitor for activin receptor-like kinase-2 (ALK2) with an IC50 of 7 nM. M4K2306 is blood brain permeable with a brain to plasma ratio of 75.6 .
loading...
    loading...
Cat. No.: HY-136773A
CAS No.: 2416307-25-8
Purity:  98.93%
Synonyms: ALK2-IN-4 succinate
Target:  

TGF-β Receptor

Research Areas:  

Metabolic Disease

KER047 succinate (ALK2-IN-4 succinate) is a potent activin receptor-like kinase-2 (ALK2) inhibitor. KER047 succinate can be used for the research of metabolic disease, such as fibrodysplasia ossificans progressiva (FOP).
loading...
    loading...
Cat. No.: HY-161376
CAS No.: 3034840-19-9
Target:  

TGF-β Receptor

Research Areas:  

Cancer

M4K2281 is a selecitve inhibitor for activin receptor-like kinase-2 (ALK2) with an IC50 of 2 nM. M4K2281 exhibits a moderate blood brain permeability with a brain to plasma ratio of 3.7 at 4h .
loading...
    loading...